These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3020314)

  • 1. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
    Kramer HJ; Baecker A; Weiler E; Liddiard C
    Klin Wochenschr; 1986 Aug; 64(16):760-6. PubMed ID: 3020314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on a low molecular weight natriuretic and Na-K-ATPase inhibitory material in urine.
    Clarkson EM; de Wardener HE
    Clin Exp Hypertens A; 1985; 7(5-6):673-83. PubMed ID: 2990768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct.
    Kramer HJ; Krampitz G; Bäcker A; Meyer-Lehnert H
    Clin Exp Hypertens; 1998; 20(5-6):557-71. PubMed ID: 9682912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
    Gonick HC; Weiler EW; Prins BA; Purdy RE
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S69-71. PubMed ID: 7508033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
    Tamura M; Harris TM; Konishi F; Inagami T
    Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endogenous natriuretic and ouabain-like factors. Their potential role in volume and blood pressure regulation].
    Kramer HJ; Bäcker A; Krampitz G; Meyer-Lehnert H; Michel H
    Klin Wochenschr; 1990 Nov; 68(22):1112-8. PubMed ID: 2177810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous natriuretic and ouabain-like factors. Their roles in body fluid volume and blood pressure regulation.
    Kramer HJ; Meyer-Lehnert H; Michel H; Predel HG
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):81-9. PubMed ID: 1848764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
    Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
    Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
    Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
    Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a low molecular weight Na-K-ATPase inhibitor of urinary origin.
    Weiler EW; Gonick HC; Prins BA; Purdy RE; Weber MA
    Am J Med Sci; 1994 Jan; 307(1):27-35. PubMed ID: 8291503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lead and natriuretic hormone on kinetics of sodium-potassium-activated adenosine triphosphatase: possible relevance to hypertension.
    Weiler E; Khalil-Manesh F; Gonick H
    Environ Health Perspect; 1988 Jun; 78():113-7. PubMed ID: 2849538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous natriuretic factors. 2: Characterization of natriuretic and vasopressive substances from human uremic urine.
    Levine BH; Murray ED; Bigornia AE; DeWind SA; Wechter WJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S63-8. PubMed ID: 7508032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-like natriuretic activity in the urine of salt loaded healthy subjects.
    Klingmüller D; Weiler E; Kramer HJ
    Klin Wochenschr; 1982 Oct; 60(19):1249-53. PubMed ID: 7144063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further characterization of the endogenous natriuretic and digoxin-like immunoreacting activities in human urine: effects of changes in sodium intake.
    Kramer HJ; Heppe M; Weiler E; Bäcker A; Liddiard C; Klingmüller D
    Ren Physiol; 1985; 8(2):80-9. PubMed ID: 4039459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ouabain-Sensitive alpha1 Na,K-ATPase enhances natriuretic response to saline load.
    Loreaux EL; Kaul B; Lorenz JN; Lingrel JB
    J Am Soc Nephrol; 2008 Oct; 19(10):1947-54. PubMed ID: 18667729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic hormone - a circulating inhibitor of sodium- and potassium-activated adenosine triphosphatase. Its potential role in body fluid and blood pressure regulation.
    Kramer HJ
    Klin Wochenschr; 1981 Nov; 59(22):1225-30. PubMed ID: 6273645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity chromatography for human Na+, K+-ATPase inhibitors in plasma and urine.
    Henning G; Cloix JF; Wainer IW; Pernollet MG; Devynck MA; Meyer P
    Life Sci; 1985 May; 36(18):1787-98. PubMed ID: 2984510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovine cardiac Na,K-ATPase: isolation by means of selective solubilization in Lubrol and the effect of 1 alpha,2 alpha-epoxyscillirosidin on this enzyme.
    Venter PA; Naudé RJ; Oelofsen W; Swan GE
    Int J Biochem Cell Biol; 1997; 29(8-9):1103-12. PubMed ID: 9416006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.